Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company.

The upfront cash payment of $4.10 per share of common stock represents a premium of around 66% to Checkpoint’s closing share ...

Sun Pharma to acquire Checkpoint Therapeutics, expanding innovative portfolio in onco-derm therapy with FDA-approved UNLOXCYT ...

Sun Pharmaceutical Industries and Checkpoint Therapeutics, Inc. (Nasdaq: CKPT) (Checkpoint) today announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an ...

Oriental Rail Infrastructure has secured its first significant order for the supply of seats for the Vande Bharat Express, India's first indigenous semi high speed train.

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Interest in human use of ivermectin grew when people began taking it to prevent or treat COVID-19, despite the FDA and other ...

Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...

Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

HHS is one of the government's costliest federal agencies, with an annual budget of about $1.7 trillion, mostly going to ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...